Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2019 | Story Valentino Ndaba | Photo Barend Nagel
BCom degree
Prospective students are invited to apply for the new BCom Business and Financial Analytics 2020 intake.

A new qualification has recently been added to the University of the Free State (UFS) curriculum and 30 prospective students still have the opportunity to form part of the BCom with specialisation in Business and Financial Analytics intake for 2020. The deadline for applications has been extended to 31 October 2019. 

Committed to the 4th industrial revolution

This flagship degree has been designed for the 4th Industrial Revolution as it integrates quantitative analysis, computer science, statistics and business. This new qualification will equip graduates to become high-functioning executives in the modern global business world. 

“The Faculty of Economic and Management Sciences identified the need for a BCom programme incorporating some of these skills in a more deliberate way, in order to prepare our graduates for a changing job market,” says Lizette Pretorius, Faculty Manager.

On par with global standards

International institutions such as Harvard Business School, Carnegie Mellon University, Duke University, and Columbia University have led the way by adopting this cohesive approach to business studies. These universities form part of a listing of the 25 top US schools offering Master’s in Business Analytics programmes. 

The UFS is following in these leading institutions as part of its Integrated Transformation Plan (ITP) to produce globally competitive graduates. According to the ITP: “The future state of engaged scholarship will be an important anchor in maintaining the relevance of the academic syllabus, and linking real local needs to the global knowledge project.”

 Click here to complete the application form. 

Please email the form and required documents to Lizette Pretorius at LPretorius@ufs.ac.za.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept